Ameriprise’s Synaptics SYNA Stock Holding History

Ameriprise’s Portfolio SYNA Stock Details SYNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-30,300	Closed	-$1.53M	–	3775
2018 Q2	$1.53M	Buy	+30,300	New	+$1.37M	﹤0.01%	2839

Other funds holding SYNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ameriprise's SYNA Position: Q2 2026 in Review

Ameriprise reduced its Synaptics (SYNA) stake by 0.87% in Q2 2026, selling an estimated $7.45M and leaving 7,481,694 shares worth $930M. The position accounts for 0.19% of the portfolio, ranked #117.

Ameriprise first reported a position in SYNA in Q2 2013 and has held it in 53 quarters since. 374 funds tracked by Wall St. Rank hold SYNA as of Q2 2026.

Ameriprise held 7,481,694 shares of Synaptics worth $930M as of Q2 2026.
Ameriprise sold 66,005 Synaptics shares in Q2 2026, an estimated $7.45M.
Synaptics made up 0.19% of Ameriprise's portfolio in Q2 2026, its #117 holding.
Ameriprise first reported a position in Synaptics in Q2 2013 and has held it in 53 quarters since.
374 funds tracked by Wall St. Rank held Synaptics as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.